116 related articles for article (PubMed ID: 23778310)
41. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients.
Cogliatti SB; Schmid U; Schumacher U; Eckert F; Hansmann ML; Hedderich J; Takahashi H; Lennert K
Gastroenterology; 1991 Nov; 101(5):1159-70. PubMed ID: 1936785
[TBL] [Abstract][Full Text] [Related]
42. Nonmucosa-associated lymphoid tissue lymphomas of gastric and intestinal origin differ in their clinical features: a single institute experience.
Chen LP; Lin SJ; Yu MS
J Chin Med Assoc; 2011 Sep; 74(9):400-7. PubMed ID: 21962248
[TBL] [Abstract][Full Text] [Related]
43. Results and prognostic factors in stage I(E)-II(E) primary gastric lymphoma after gastrectomy.
Rodríguez-Sanjuán JC; Alvarez-Cañas C; Casado F; García-Castrillo L; Casanova D; Val-Bernal F; Naranjo A
J Am Coll Surg; 1999 Mar; 188(3):296-303. PubMed ID: 10065819
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological characteristics and therapeutic outcomes of synchronous gastric adenocarcinoma and gastric lymphoma.
Namikawa T; Munekage E; Fukudome I; Maeda H; Kitagawa H; Togitani K; Takasaki M; Yokoyama A; Kobayashi M; Hanazaki K
Anticancer Res; 2014 Sep; 34(9):5067-74. PubMed ID: 25202092
[TBL] [Abstract][Full Text] [Related]
45. Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001.
Thieblemont C; Dumontet C; Bouafia F; Hequet O; Arnaud P; Espinouse D; Felman P; Berger F; Salles G; Coiffier B
Leuk Lymphoma; 2003 Feb; 44(2):257-62. PubMed ID: 12688342
[TBL] [Abstract][Full Text] [Related]
46. Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma.
Ferreri AJ; Cordio S; Ponzoni M; Villa E
Leuk Lymphoma; 1999 May; 33(5-6):531-41. PubMed ID: 10342580
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological characteristics and prognostic factors of primary gastrointestinal lymphoma: a 22-year experience from South China.
Li M; Zhang S; Gu F; Xiao W; Yao J; Chao K; Chen M; Li J; Zhong B
Int J Clin Exp Pathol; 2014; 7(5):2718-28. PubMed ID: 24966993
[TBL] [Abstract][Full Text] [Related]
48. Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG).
Cortelazzo S; Rossi A; Roggero F; Oldani E; Zucca E; Tondini C; Ambrosetti A; Pasini F; Pinotti G; Bertini M; Vitolo U; Busetto M; Gianni L; Cavalli F; Barbui T
Ann Oncol; 1999 Dec; 10(12):1433-40. PubMed ID: 10643533
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study.
Terada M; Kinoshita T; Kaito A; Sugita S; Watanabe M; Hayashi R
Surg Today; 2018 Mar; 48(3):325-332. PubMed ID: 28993997
[TBL] [Abstract][Full Text] [Related]
50. Non-Hodgkin's lymphoma of the stomach.
Mittal B; Wasserman TH; Griffith RC
Am J Gastroenterol; 1983 Dec; 78(12):780-7. PubMed ID: 6650467
[TBL] [Abstract][Full Text] [Related]
51. [Significant prognostic factors in stage IV gastric cancer].
Suzuki O; Fukuchi M; Onozawa H; Chika N; Hatano S; Imaizumi H; Matsuzawa T; Ishiguro T; Kuwabara K; Sobajima J; Sakimoto T; Baba H; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1310-2. PubMed ID: 25335727
[TBL] [Abstract][Full Text] [Related]
52. Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer.
Greenleaf EK; Kulaylat AN; Hollenbeak CS; Almhanna K; Wong J
Ann Surg Oncol; 2016 Dec; 23(13):4203-4213. PubMed ID: 27459982
[TBL] [Abstract][Full Text] [Related]
53. Analysis of prognostic factors in localized gastric lymphoma: the importance of bulk of disease.
Valicenti RK; Wasserman TH; Kucik NA
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):591-8. PubMed ID: 8226153
[TBL] [Abstract][Full Text] [Related]
54. Treatment of early-stage gastric lymphoma.
Ben-Yosef R; Hoppe RT
J Surg Oncol; 1994 Oct; 57(2):78-86. PubMed ID: 7934067
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological features and outcomes of patients with gastric cancer: a single-center experience.
Selcukbiricik F; Buyukunal E; Tural D; Ozguroglu M; Demirelli F; Serdengecti S
World J Gastroenterol; 2013; 19(14):2154-61. PubMed ID: 23599641
[TBL] [Abstract][Full Text] [Related]
56. [Radiological findings in malignant lymphoma of the stomach].
Majewski A; Meyer HJ; Emminger A
Rofo; 1984 Aug; 141(2):160-6. PubMed ID: 6431537
[TBL] [Abstract][Full Text] [Related]
57. Primary gastric lymphoma. Problems in staging and management.
Jones RE; Willis S; Innes DJ; Wanebo HJ
Am J Surg; 1988 Jan; 155(1):118-23. PubMed ID: 2449090
[TBL] [Abstract][Full Text] [Related]
58. Retrospective analysis of primary gastric diffuse largeB-cell lymphoma: a single center study from Turkey.
Soyer N; Yilmaz AF; Özsan N; Şahin F; Saydam G; Tombuloğlu M; Hekimgil M; Vural F
Turk J Med Sci; 2017 Feb; 47(1):240-245. PubMed ID: 28263496
[TBL] [Abstract][Full Text] [Related]
59. A retrospective analysis of clinicopathological characteristics, treatment, and outcome of 27 patients of primary intestinal lymphomas.
Khosla D; Kumar R; Kapoor R; Kumar N; Bera A; Sharma SC
J Gastrointest Cancer; 2013 Dec; 44(4):417-21. PubMed ID: 23820932
[TBL] [Abstract][Full Text] [Related]
60. Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patients.
Schildberg CW; Croner R; Schellerer V; Haupt W; Schildberg FW; Schildberg M; Hohenberger W; Horbach T
Adv Med Sci; 2012; 57(2):259-65. PubMed ID: 23314560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]